Article thumbnail

Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients

By Juergen Graessler, Dominik Schwudke, Peter E. H. Schwarz, Ronny Herzog, Andrej Shevchenko and Stefan R. Bornstein
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2705678
Provided by: PubMed Central

Suggested articles

Citations

  1. (1986). A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.
  2. (2005). A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry.
  3. (2007). Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study.
  4. (2006). Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
  5. (2008). Application of the accurate mass and time tag approach in studies of the human blood lipidome.
  6. (2008). Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey,
  7. (2006). Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning.
  8. (2005). Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry.
  9. (2009). Cellular Mediators of Renal Vascular Dysfunction in Hypertension.
  10. (2003). Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation.
  11. (2006). Collisioninduced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion traporbitrap mass spectrometry.
  12. (2008). Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat.
  13. (2004). Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids.
  14. (2009). Endothelial Dysfunction.
  15. (2007). Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles.
  16. (2004). Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells.
  17. (1991). Fat distribution and gender differences in serum lipids in men and women from four European communities.
  18. (2007). Free cholesterol in atherosclerotic plaques: where does it come from?
  19. (2009). Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry.
  20. (2006). High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS).
  21. (2009). High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study.
  22. (2004). Highthroughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm.
  23. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
  24. (2003). Human adipocytes secrete mineralocorticoidreleasing factors.
  25. (1998). Hypertension: where have we gone wrong and how can we fix it?
  26. (1983). Inactivation of 1-alkyl-2-acetylsn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.
  27. (1988). Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat.
  28. (2008). Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics.
  29. (2006). Lipid profiling by multiple precursor and neutral loss scanning driven by the datadependent acquisition.
  30. (2009). Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry.
  31. (2007). Normalization method for metabolomics data using optimal selection of multiple internal standards.
  32. (2008). Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC)
  33. (2007). Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.
  34. (2009). Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.
  35. (2009). Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension.
  36. (1991). Relationship between insulin resistance and hypertension.
  37. (2006). Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
  38. (2007). Shevchenko A
  39. (2006). Software tools for analysis of mass spectrometric lipidome data.
  40. (2008). The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF1alpha) is associated with insulin sensitivity and beta-cell function.
  41. (2008). Tol A
  42. (2007). Top-down lipidomic screens by multivariate analysis of high-resolution survey mass spectra.
  43. (2008). Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism–the GENOBIN study.
  44. (2009). Vascular endothelium in atherosclerosis.
  45. (2009). Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.